Which FDA guid­ance doc­u­ments are com­ing for drug­mak­ers in 2022? Agency un­veils new lists

Each year, the FDA’s cen­ters for drugs and bi­o­log­ics plot out which pri­or­i­ties to ad­dress in guid­ance to in­dus­try, pro­vid­ing ad­di­tion­al help on reg­u­la­to­ry par­tic­u­lar­i­ties …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER